Carbohydrate deficient transferrin: a marker for alcohol abuse

Area of Science:

• Biochemistry
• Clinical Diagnostics
• Addiction Medicine

Background:

• Alcohol abuse is a significant public health concern with various diagnostic challenges.
• Current laboratory tests for alcohol abuse have limitations in sensitivity and specificity.
• Carbohydrate deficient transferrin (CDT) has emerged as a potential biomarker for chronic alcohol consumption.

Purpose of the Study:

• To evaluate the diagnostic value of serum carbohydrate deficient transferrin (CDT) detected by isoelectric focusing on agarose.
• To compare the efficacy of CDT as an alcohol abuse indicator against standard laboratory tests.

Main Methods:

• Serum samples were analyzed from patients with defined alcohol intake, including those with and without liver disease.
• A coded analysis was performed on samples from self-confessed alcoholics, patients with alcoholic liver disease, non-alcoholic liver disorders, and controls.
• Serial studies were conducted on patients undergoing alcohol withdrawal to observe CDT changes over time.

Main Results:

• Serum CDT was detected in 86% of self-confessed alcohol abusers, compared to 3% in controls and 0% in non-alcoholic liver disease patients.
• CDT levels decreased after alcohol withdrawal, with detectability persisting for up to 15 days in some individuals.
• CDT demonstrated significantly higher sensitivity and accuracy in detecting alcohol abuse compared to conventional markers.

Conclusions:

• Serum carbohydrate deficient transferrin (CDT) is a sensitive and reliable biomarker for detecting alcohol abuse.
• The technique for CDT detection is simple, sensitive, and cost-effective, suggesting its clinical utility.
• CDT offers a valuable tool for identifying individuals with problematic alcohol consumption.